blgo: the income statement

MyFinsight

BIOLARGO, INC. (BLGO)

For the quarter ending 2025-06-30, BLGO made $2,777K in revenue. -$1,192K in net income. Net profit margin of -42.92%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30	2025-03-31	2024-09-30	2024-06-30
Revenue from contract with customer, including assessed tax	2,777	3,269	4,351	5,014
Service	449	-	-	-
Product	907	-	-	-
Cost of goods and services sold	1,356	1,781	2,629	2,877
Gross profit	1,421	1,488	1,722	2,137
Selling, general and administrative expenses	2,688	2,559	2,093	2,404
Research and development	535	791	690	623
Total operating expenses	3,223	3,350	2,783	3,027
Operating loss	-1,802	-1,862	-1,061	-890
Interest expense	-80	-65	1	-
Grant income	-	6	-	15
Ppp loan forgiveness	-	-	-	97
Total other expense	-80	-59	-	-
Us-gaap_interestexpense	-	-	-	2
Us-gaap_othernonoperatingincomeexpense	-	-	1	110
Net loss	-1,882	-1,921	-1,060	-780
Net loss attributable to noncontrolling interest	-690	-766	-523	-339
Net loss attributable to common shareholders	-1,192	-1,155	-537	-441

Loss per share attributable to shareholders basic and diluted (in dollars per share)	-0.004	-0.004	-0.002	-0.001
Weighted average number of common shares outstanding (in shares)	303,196,989	301,274,243	300,488,824	296,436,219

Unit: Thousand (K) dollars (except for numbers of shares and EPS)